Biography
Gudrun specializes in developing advanced genomics platforms, drawing on her experience in NGS development and background in biophysics and biochemistry. She has made significant contributions to the field, including the development of the NovaSeq platform at Illumina, and the Aviti platform at Element. In the startup space, she played a key role in securing Series B funding for Encodia through her work in proteomics. Currently, as the founder of Alida Biosciences, Gudrun is focused on creating novel RNA epitranscriptomic technologies designed to advance beyond primary transcriptomic sequence analysis, to empower a new frontier of RNA biology and enhancement of multi-omic studies.